Broker notes, analysis and comments
Avacta Group Plc (LON: AVCT) is a pre-clinical stage biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology. The significant..
Inchcape PLC (LON:INCH) is a unique global distributor operating in 32 markets globally across the automotive value chain. The group has a long track record in effective capital allocation, delivering..
Ceres Power (LON:CWR) Further to Tuesday’s meaningful update on Weichai, Ceres has provided positive guidance ahead of its H1/FY2019 end. Management anticipates revenue to be at least £7m for the..
On 3 December, Non-Standard Finance (LON:NSF) held an investor day at the Reading branch of Everyday Loans (EL) and its head office in Bourne End. Investors and analysts thus got..
Ceres Power Plc (LON:CWR) has confirmed that the second tranche of the equity investment from Weichai Power (Weichai) is being made as planned for £28.0m. This takes Weichai’s equity holding..
Lookers Plc (LON:LOOK), We note the recent under performance of the shares of late and believe the current price to be an attractive entry point for investors. Lookers has a..
REDX Pharma (LON:REDX) is a clinical-stage biotechnology company focused on drugs targeting oncology and fibrotic diseases. An extensive review, led by the new CEO, has reinforced the vision of a..
XPS Pensions Group (LON:XPS) interim results to 30 September 2018 are the maiden results for the combined group (Xafinity acquired businesses from Punter Southall Group in January 2018). In summary..
BCA Marketplace Plc (LON:BCA) has delivered another strong set of results, which are 6% ahead of our forecasts at the adjusted PBT level. The strong YOY growth delivered across all..
Palace Capital (LON:PCA) reported 1H’19 (six months to September 2018) results on 26 November, in line with expectations. We reduce our forward estimates due to disposal and minor trimming of..
Redx Pharma (LON:REDX) is a clinical-stage R&D company focused on drugs targeting oncology and fibrotic disease. 2018 was a year that reset the benchmarks – new management team, restructured organisation..
Today we confirm our forecasts for FY(Mar)19E and FY(Mar)20E for Tatton Asset Management (LON:TAM) and publish for the first time our forecasts for FY(Mar)21E. Key points in this note include:..
Cambria Automobiles (LON:CAMB) has delivered a robust FY 2018 performance, in the context of a challenging new car market, which was ahead of our forecasts at the adjusted EPS level..
The 600 Group (LON:SIXH) remains competitively well positioned, with a world-class reputation in machine tools and laser marking. Around 65% of sales are in the US. Business momentum is good,..
The Platinum-certified album of the same name by Elvis Costello is widely held to be the most impressive debut in popular music history; and it ranks 80 in the greatest..
Tatton Asset Management (LON:TAM), interim results to 30 September 2018 reveal: 29.5% YoY rise in Tatton’s assets under management to £5.7bn (Sept 18: £4.4bn); an increase of £0.8bn in..
We note the unscheduled trading update released this morning by Marshall Motor Holdings (LON:MMH), confirming better than expected trading in the used car market. Together with continued growth in the..
Haydale Graphene Industries Plc (LON:HAYD), Financial issues are now likely to affect the shares in the near term, as the group seeks new working capital funding arrangements. However, commercial developments..
REDX Pharma (LON:REDX) new management team is continuing to focus its financial resources on progressing lead candidates in oncology and fibrotic disease into the clinic. An extensive internal review, led..
Alliance Pharma (LON:APH) is a profitable, cash-generative, specialty pharma business. The proportion of sales generated from higher margin international star brands is rising rapidly, and will be boosted by the..
